Therapeutic and Prophylactic Drugs to Treat Orthopoxvirus Infections
- 24 October 2008
- journal article
- Published by Taylor & Francis in Future Virology
- Vol. 3 (6) , 595-612
- https://doi.org/10.2217/17460794.3.6.595
Abstract
With the global eradication of smallpox in 1979, the causative agent, variola, no longer circulates in human populations. Other human poxvirus infections, such as those caused by vaccinia, cowpox v...Keywords
Funding Information
- Chimerix, Inc (U54 AI057233)
- NIAID (NOI-AI015436, U54-AI-057160)
This publication has 107 references indexed in Scilit:
- Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress InhibitorAntimicrobial Agents and Chemotherapy, 2008
- Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template StrandAntimicrobial Agents and Chemotherapy, 2008
- Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challengeVaccine, 2007
- Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virusAntiviral Research, 2007
- Synergistic Efficacy of the Combination of ST-246 with CMX001 against OrthopoxvirusesAntimicrobial Agents and Chemotherapy, 2007
- Effect of Oral Treatment with Hexadecyloxypropyl-[( S )-9-(3-Hydroxy-2- Phosphonylmethoxypropyl)Adenine] [( S )-HPMPA] or Octadecyloxyethyl-( S )-HPMPA on Cowpox or Vaccinia Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007
- Antiviral activity of human β-defensin 3 against vaccinia virusJournal of Allergy and Clinical Immunology, 2007
- Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007
- Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance PhenotypeAntimicrobial Agents and Chemotherapy, 2006
- Acyclic nucleoside phosphonates: a key class of antiviral drugsNature Reviews Drug Discovery, 2005